- Home
- UGRO vs SBFM Comparison
UGRO vs SBFM Comparison
Compare UGRO & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- SBFM
- Stock Information
- Founded
- UGRO 2014
- SBFM 2006
- Country
- UGRO United States
- SBFM United States
- Employees
- UGRO N/A
- SBFM N/A
- Industry
- UGRO Industrial Specialties
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- SBFM Health Care
- Exchange
- UGRO Nasdaq
- SBFM Nasdaq
- Market Cap
- UGRO 5.5M
- SBFM 4.6M
- IPO Year
- UGRO N/A
- SBFM N/A
- Fundamental
- Price
- UGRO $0.39
- SBFM $1.51
- Analyst Decision
- UGRO Strong Buy
- SBFM Strong Buy
- Analyst Count
- UGRO 1
- SBFM 1
- Target Price
- UGRO $3.00
- SBFM $15.00
- AVG Volume (30 Days)
- UGRO 117.3K
- SBFM 104.8K
- Earning Date
- UGRO 06-17-2025
- SBFM 05-15-2025
- Dividend Yield
- UGRO N/A
- SBFM N/A
- EPS Growth
- UGRO N/A
- SBFM N/A
- EPS
- UGRO N/A
- SBFM N/A
- Revenue
- UGRO $59,985,133.00
- SBFM $36,234,578.00
- Revenue This Year
- UGRO N/A
- SBFM $192.48
- Revenue Next Year
- UGRO $31.25
- SBFM N/A
- P/E Ratio
- UGRO N/A
- SBFM N/A
- Revenue Growth
- UGRO N/A
- SBFM 35.51
- 52 Week Low
- UGRO $0.29
- SBFM $1.17
- 52 Week High
- UGRO $1.92
- SBFM $11.39
- Technical
- Relative Strength Index (RSI)
- UGRO 49.87
- SBFM 54.20
- Support Level
- UGRO $0.29
- SBFM $1.37
- Resistance Level
- UGRO $0.42
- SBFM $1.56
- Average True Range (ATR)
- UGRO 0.03
- SBFM 0.08
- MACD
- UGRO 0.01
- SBFM 0.02
- Stochastic Oscillator
- UGRO 76.92
- SBFM 73.68
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.